<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06726</article-id><article-id pub-id-type="doi">10.7554/eLife.06726</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>The hormonal peptide Elabela guides angioblasts to the midline during vasculogenesis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-28584"><name><surname>Helker</surname><given-names>Christian S M</given-names></name><aff><institution content-type="dept">n/a</institution>, <institution>University of Muenster</institution>, <addr-line><named-content content-type="city">Muenster</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28585"><name><surname>Schuermann</surname><given-names>Annika</given-names></name><aff><institution content-type="dept">n/a</institution>, <institution>University of Muenster</institution>, <addr-line><named-content content-type="city">Muenster</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28586"><name><surname>Pollmann</surname><given-names>Cathrin</given-names></name><aff><institution content-type="dept">n/a</institution>, <institution>Max Planck Institute for Molecular Biomedicine</institution>, <addr-line><named-content content-type="city">Muenster</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28587"><name><surname>Chng</surname><given-names>Serene C</given-names></name><aff><institution content-type="dept">Institute of Medical Biology, Human Genetics and Embryology Laboratory</institution>, <institution>A*STAR</institution>, <addr-line><named-content content-type="city">Singapore</named-content></addr-line>, <country>Singapore</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33806"><name><surname>Kiefer</surname><given-names>Friedemann</given-names></name><aff><institution content-type="dept">n/a</institution>, <institution>Max Planck Institute for Molecular Biomedicine</institution>, <addr-line><named-content content-type="city">Muenster</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28355"><name><surname>Reversade</surname><given-names>Bruno</given-names></name><aff><institution content-type="dept">Institute of Medical Biology, Human Genetics and Embryology Laboratory</institution>, <institution>A*STAR</institution>, <addr-line><named-content content-type="city">Sinagapore</named-content></addr-line>, <country>Singapore</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-28001"><name><surname>Herzog</surname><given-names>Wiebke</given-names></name><aff><institution content-type="dept">n/a</institution>, <institution>University of Muenster</institution>, <addr-line><named-content content-type="city">Muenster</named-content></addr-line>, <country>Germany</country><email>wiebke.herzog@mpi-muenster.mpg.de</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1203"><name><surname>Whitfield</surname><given-names>Tanya T</given-names></name><role>Reviewing editor</role><aff><institution>University of Sheffield</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>05</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06726</elocation-id><supplementary-material><ext-link xlink:href="elife-06726-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>27</day><month>01</month><year>2015</year></date><date date-type="accepted"><day>22</day><month>05</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Helker et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Helker et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>A key step in the <italic>de novo</italic> formation of the embryonic vasculature is the migration of endothelial precursors, the angioblasts, to the position of the future vessels. To form the first axial vessels, angioblasts migrate towards the midline and coalesce underneath the notochord. Vascular endothelial growth factor (Vegf) has been proposed to serve as a chemoattractant for the angioblasts and to regulate this medial migration. Here we challenge this model and instead demonstrate that angioblasts rely on their intrinsic expression of Apelin receptors (Aplr, APJ) for their migration to the midline. We further show that during this angioblast migration Apelin receptor signaling is mainly triggered by the recently discovered ligand Elabela (Ela). As neither of the ligands Ela or Apelin (Apln) nor their receptors have previously been implicated in regulating angioblast migration, we hereby provide a novel mechanism for regulating vasculogenesis, with direct relevance to physiological and pathological angiogenesis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were performed in strict accordance with the relevant laws and institutional guidelines the Max Planck Institute for Molecular Biomedicine, Muenster and the Institute of Medical Biology, Singapore. All protocols were approved by animal ethics committees of the state of North Rhine-Westfalia (Germany,# 39.32.7.1) and Singapore, respectively, and all efforts were made to minimize suffering.</p></fn></fn-group></back></article>